ENDRA Life Sciences logo

ENDRA Life Sciences

NDRA | NASDAQ
Chart Builder DCF Calculator
$4.42
+$0.01 (+0.23%)
At close: Nov 16, 2026, 4:00 PM ET
$4.42
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:11 PM ET
+0.23%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #836/1021 (Top 82%)

Key Statistics

Market Data

Market Cap $6.63M
1D Range
4.32 4.46
52W Range
3.26 6.69

Valuation (TTM)

PE -0.69
PB 1.05
EV/EBITDA -0.72

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $25.00
Loading financial charts...

Profile

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operate...

Sector Healthcare
Employees 10
IPO Date Jun 30, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$25.00
Upside
+465.61%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.